Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial - Wikidata - awgldk - TriplyDB

Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial

Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial

http://www.wikidata.org/entity/Q34381324

about

Fortnightly review: gallbladder disease.Review article: epidemiology of gall-bladder disease--role of intestinal transit.Gallstones and cholecystectomy in modern Britain Effect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans Gastroenterology--II: Small and large bowel, pancreas and biliary system.Percutaneous cholecystolithotomy: risks, benefits, and long-term outcome.Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile.Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.

P2860

Q24524318-9438562F-D344-47CC-9833-42E798EECDCF Q33973591-1B820DC5-1479-473E-BAB3-D279467D662E Q35509985-02C89D81-2B54-472E-9600-192DDA417999 Q35960449-38B7FBD4-B514-4F33-9D1F-24D3299C407D Q36679233-FD20BBDD-3311-4965-B225-AA2D5864C943 Q42680499-DF96F046-CE9F-41A1-8D6F-AFE897DE32B2 Q43734581-CC4CD109-9616-48B7-A5BC-4ED6B31DE358 Q44632248-70399135-7B29-4A2C-A119-38B5811B2236

P2860

Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial

http://www.wikidata.org/entity/Q34381324

description

1993 nî lūn-bûn

@nan

1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Gall stone recurrence and its ...... Group's post-dissolution trial

@ast

Gall stone recurrence and its ...... Group's post-dissolution trial

@en

Gall stone recurrence and its ...... Group's post-dissolution trial

@nl

type

label

Gall stone recurrence and its ...... Group's post-dissolution trial

@ast

Gall stone recurrence and its ...... Group's post-dissolution trial

@en

Gall stone recurrence and its ...... Group's post-dissolution trial

@nl

prefLabel

Gall stone recurrence and its ...... Group's post-dissolution trial

@ast

Gall stone recurrence and its ...... Group's post-dissolution trial

@en

Gall stone recurrence and its ...... Group's post-dissolution trial

@nl

P1433

Q34381324-940E4788-78F0-41D0-880B-BBC783FC7F8A

P1476

Q34381324-77AEF983-D9A5-47E0-A395-72333C71F8EC

P2093

Q34381324-287D3346-DB29-4E7F-AFD2-601F6034D3DE

Q34381324-31324F15-7C72-40BC-BA0E-37F91BDA2521

Q34381324-643C569A-5515-47B6-B88B-EBB1FEC9ACEE

Q34381324-868EAB08-47D9-46A4-AF18-D029EEED9FEC

P2860

Q34381324-07DF7E40-21B3-439B-95B6-C98254AB5967

Q34381324-148AACE3-7924-4C94-A9C2-2C458B7020C1

Q34381324-1493824C-B680-43F8-A565-4EDE78B3713A

Q34381324-2BAE0A06-B5CE-45AB-97D2-E534B86E32E1

Q34381324-32226B71-E1BA-45E4-9F63-7C9E1266052B

Q34381324-3C76E4F0-2429-48F8-B95D-BF424F2E7662

Q34381324-423143CA-AAE1-4D30-8B25-BB07F8631E9E

Q34381324-484CB591-E940-47F9-A799-B4A43B8B098A

Q34381324-553B38E9-80FD-43B1-A77E-A39CD82A534C

Q34381324-56AFC01D-5276-4968-A5F3-FCB7ABC33FAE

P304

Q34381324-D9D50863-0CAD-460C-8CC0-3A08FC163D01

P31

Q34381324-35D74EFC-2A4B-4DA7-9632-A784E24FA74D

P356

Q34381324-B1BAB6F5-79C4-4928-A2AB-60FAD7411C26

P407

Q34381324-922118D7-32FC-4FD4-84BE-866493B1EA74

P433

Q34381324-E1845633-C8BA-4E52-862E-958A8FC93CD3

P478

Q34381324-D8A83762-19EF-414D-B855-345B565638A1

P577

Q34381324-6AA635B6-B9B1-4C84-9A53-C6B413F1199C

P5875

Q34381324-E295510E-7DA6-45D5-981E-88A24EA88D53

P698

Q34381324-AD2788B5-4D1A-47DC-AEB3-73238D1BF533

P932

Q34381324-0091B2BE-C1A4-4882-A820-F73FB822F64E

P356

P1433

P1476

Gall stone recurrence and its ...... Group's post-dissolution trial

@en

P2093

D C Ruppin

http://www.w3.org/2001/XMLSchema#string

D Gleeson

http://www.w3.org/2001/XMLSchema#string

K A Hood

http://www.w3.org/2001/XMLSchema#string

R H Dowling

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight

Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.

Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.

Gall stones in a Danish population: fertility period, pregnancies, and exogenous female sex hormones.

Gall-stone dissolution and recurrence: are we being misled?

The physicochemical basis of cholesterol gallstone formation in man.

Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?

Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones

Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism.

P304

1277-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.34.9.1277

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1993-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14793478

http://www.w3.org/2001/XMLSchema#string

P698

8406169

http://www.w3.org/2001/XMLSchema#string

P932

1375471

http://www.w3.org/2001/XMLSchema#string